1. Home
  2. INKT vs OKYO Comparison

INKT vs OKYO Comparison

Compare INKT & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INKT
  • OKYO
  • Stock Information
  • Founded
  • INKT 2017
  • OKYO 2007
  • Country
  • INKT United States
  • OKYO United Kingdom
  • Employees
  • INKT N/A
  • OKYO N/A
  • Industry
  • INKT Medicinal Chemicals and Botanical Products
  • OKYO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • INKT Health Care
  • OKYO Health Care
  • Exchange
  • INKT Nasdaq
  • OKYO Nasdaq
  • Market Cap
  • INKT 31.2M
  • OKYO 37.0M
  • IPO Year
  • INKT 2021
  • OKYO 2022
  • Fundamental
  • Price
  • INKT $7.14
  • OKYO $1.87
  • Analyst Decision
  • INKT Strong Buy
  • OKYO Strong Buy
  • Analyst Count
  • INKT 2
  • OKYO 1
  • Target Price
  • INKT $37.50
  • OKYO $7.00
  • AVG Volume (30 Days)
  • INKT 5.5K
  • OKYO 199.9K
  • Earning Date
  • INKT 05-15-2025
  • OKYO 06-13-2025
  • Dividend Yield
  • INKT N/A
  • OKYO N/A
  • EPS Growth
  • INKT N/A
  • OKYO N/A
  • EPS
  • INKT N/A
  • OKYO N/A
  • Revenue
  • INKT N/A
  • OKYO N/A
  • Revenue This Year
  • INKT N/A
  • OKYO N/A
  • Revenue Next Year
  • INKT N/A
  • OKYO N/A
  • P/E Ratio
  • INKT N/A
  • OKYO N/A
  • Revenue Growth
  • INKT N/A
  • OKYO N/A
  • 52 Week Low
  • INKT $4.56
  • OKYO $0.81
  • 52 Week High
  • INKT $13.79
  • OKYO $1.98
  • Technical
  • Relative Strength Index (RSI)
  • INKT 47.31
  • OKYO 61.51
  • Support Level
  • INKT $6.89
  • OKYO $1.67
  • Resistance Level
  • INKT $7.25
  • OKYO $1.98
  • Average True Range (ATR)
  • INKT 0.42
  • OKYO 0.19
  • MACD
  • INKT 0.01
  • OKYO 0.01
  • Stochastic Oscillator
  • INKT 39.70
  • OKYO 82.81

About INKT MiNK Therapeutics Inc.

MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Share on Social Networks: